Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,934.00    44.00 (0.90%)
Bid:
4,966.00
Ask:
4,968.00
Spread: 2.00 (0.04%)
Market Cap: £17.98b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Director/PDMR Shareholding

1 Sep 2023 11:51

RNS Number : 1452L
Coca-Cola HBC AG
01 September 2023
Β 

FOR IMMEDIATE RELEASE

01 September 2023

Β 

Coca-Cola HBC AG (the "Company")

Notification of transactions by Persons Discharging Managerial Responsibilities ("PDMRs')

The Company has been notified that the following PDMR sold ordinary shares of CHF 6.70 each in the Company on 31 August 2023.

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

a)

Β 

Name

Β 

ZORAN BOGDANOVIC

2

Β 

Reason for the notification

a)

Β 

Position/status

Β 

CHIEF EXECUTIVE OFFICER

b)

Β 

Initial notification /Amendment

Β 

INITIAL NOTIFICATION

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Β 

Name

Β 

COCA-COLA HBC AG

b)

Β 

LEI

Β 

549300EFP3TNG7JGVE49

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Β 

COCA-COLA HBC AG ORDINARY SHARES OF CHF 6.70 EACH ("SHARES")

Β 

CH0198251305

b)

Β 

Nature of the transaction

Β 

Β 

SALE OF 5,528 SHARES AT GBP 23.15 PER SHARE, RESULTING IN THE NET AMOUNT OF APPROX GBP 127,493

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Volume(s)

23.15 GBP

5,528

Β 

Β 

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Price

Volume

Total

23.15 GBP

5,528

127,973.20 GBP

e)

Β 

Date of the transaction

Β 

2023-08-31

Β 

f)

Β 

Place of the transaction

Β 

XLON

Β 

This notification is made in accordance with the requirements of the UK Market Abuse Regulation and EU Market Abuse Regulation.

For further information please contact:

Jan Gustavsson

General Counsel and Company Secretary

+41 (0) 41 726 01 10

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHNKDBQKBKDFCK
Date   Source Headline
16th May 20177:11 amRNSNotice of AGM
15th May 20177:23 amRNSchange to the Board and confirms dividend dates
11th May 20177:00 amRNSYEAR STARTS WELL WITH GOOD REVENUE GROWTH
2nd May 20179:07 amRNSIssue of Equity and Total Voting Rights
2nd May 20178:48 amRNSBlock listing Interim Review
28th Apr 20174:53 pmRNSCoca-Cola HBC Finance B.V. - Annual Report 2016
19th Apr 20174:24 pmRNSDirector/PDMR Shareholding
10th Apr 20173:07 pmRNSNotice of Results
3rd Apr 20178:14 amRNSIssue of Equity and Total Voting Rights
21st Mar 20171:09 pmRNSDirector/PDMR Shareholding
21st Mar 20179:21 amRNSDirector/PDMR Shareholding
17th Mar 20179:15 amRNS2016 Integrated Annual Report
1st Mar 20177:36 amRNSIssue of Equity and Total Voting Rights
20th Feb 20172:37 pmRNSDirector/PDMR Shareholding
16th Feb 20177:00 amRNSCONTINUED GOOD PROGRESS IN MARGIN RECOVERY
1st Feb 20179:55 amRNSIssue of Equity and Total Voting Rights
23rd Jan 20172:14 pmRNSNotice of Results
23rd Jan 20179:12 amRNSDirector/PDMR Shareholding
9th Jan 20179:57 amRNSAthens Exchange trading date of ordinary shares
3rd Jan 20179:28 amRNSIssue of Equity and Total Voting Rights
20th Dec 20162:39 pmRNSDirector/PDMR Shareholding
18th Nov 20161:48 pmRNSDirector/PDMR Shareholding
3rd Nov 20167:00 amRNSSOLID QUARTER CONFIRMS FULL-YEAR EXPECTATIONS
1st Nov 20167:00 amRNSBlock listing Interim Review
1st Nov 20167:00 amRNSIssue of Equity and Total Voting Rights
19th Oct 20162:50 pmRNSDirector/PDMR Shareholding
18th Oct 20169:00 amRNSNotice of Results
3rd Oct 20169:05 amRNSIssue of Equity and Total Voting Rights
20th Sep 20162:06 pmRNSDirector/PDMR Shareholding
16th Sep 20161:42 pmRNSSale of a 50% shareholding in Neptunas to TCCC
1st Sep 20167:00 amRNSCancellation of Treasury Shares, Issue of Equity
23rd Aug 20162:11 pmRNSDirector/PDMR Shareholding
18th Aug 201610:04 amRNSDirector/PDMR Shareholding
16th Aug 201611:26 amRNSDirector/PDMR Shareholding
11th Aug 20167:00 amRNSTOPLINE GROWTH DELIVERS PROFIT & MARGIN EXPANSION
1st Aug 20167:53 amRNSIssue of Equity and Total Voting Rights
29th Jul 20162:55 pmRNSDirector/PDMR Shareholding
29th Jul 20169:50 amRNSRESULTS FOR THE SIX MONTHS ENDED 1 JULY 2016
25th Jul 20162:56 pmRNSDirector/PDMR Shareholding
14th Jul 20169:40 amRNSNotice of Results
1st Jul 201611:33 amRNSDirector/PDMR Shareholding
1st Jul 20167:49 amRNSIssue of Equity and Total Voting Rights
27th Jun 20166:24 pmRNSDirector/PDMR Shareholding
27th Jun 20161:46 pmRNSChairman Emeritus
22nd Jun 20168:44 amRNSResult of AGM
22nd Jun 20168:13 amRNSDirectorate Change
22nd Jun 20167:56 amRNSResult of AGM
8th Jun 20169:54 amRNSAthens Exchange trading date of ordinary shares
6th Jun 201612:00 pmRNSStrategy/Company/Ops Update
31st May 20163:28 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.